LECAP Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $594K | Buy |
10,802
+980
| +10% | +$53.9K | 0.21% | 177 |
|
|
2025
Q1 | $694K | Buy |
9,822
+1,330
| +16% | +$94K | 0.16% | 210 |
|
|
2024
Q4 | $558K | Sell |
8,492
-5,863
| -41% | -$385K | 0.15% | 210 |
|
|
2024
Q3 | $1.01M | Buy |
+14,355
| New | +$1.01M | 0.22% | 170 |
|
|
2024
Q2 | – | Sell |
-11,000
| Closed | -$961K | – | 323 |
|
|
2024
Q1 | $961K | Buy |
11,000
+4,658
| +73% | +$407K | 0.2% | 189 |
|
|
2023
Q4 | $611K | Buy |
+6,342
| New | +$611K | 0.22% | 170 |
|